## OSCR: Oscar Health, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -1.0% below STRENGTH zone (3.0-6.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($13.96)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | Stephens & Co. | $17 | $0 | 0% |
| 2025-11-26 | Piper Sandler | $25 | $13 | +92% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | Stephens & Co. | init | Equal-Weight |
| 2025-11-26 | Piper Sandler | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.09M) |
| Sells | 7 ($1.04M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (+2.1%)
- Blackrock Inc.: 7.1% (+2.7%)
- T. Rowe Price Invest: 3.6% (-34.3%)
- Thrive Capital Manag: 2.8% (0.0%)
- American Century Com: 2.3% (+89.0%)

### Key Risks

1. High beta (1.88) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Elevated short interest (13.6%): bears positioning against stock.
3. Near-term weakness: 8.6% below SMA50 despite long-term uptrend.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

Analyst sentiment positive (1 raises, avg +92%). Insider selling cluster ($1.0M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $4.6B |
| Beta | 1.88 |
| 52W Range | $11.20 - $23.80 |
| Short Interest | 13.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | N/A |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 improving modestly (+0.7% over 5 days). Below STRENGTH zone by 4.0pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.9%) - potential reversal signal. RSI neutral at 48. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.98% (CS: 19) | Neutral |
| RSI_14 | 47.5 | Neutral |
| MACD Histogram | 0.07 | Bullish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 0.914x | Below |
| vs SMA200 | 1.004x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $16.14
- **Stop Loss:** $13.96 (13.5% risk)
- **Target:** $18.32 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 550
- **Position Value:** $8,877.00
- **Portfolio %:** 8.88%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-03 (Est: $-0.92)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.58 | $-0.53 | +8.6% |
| 2025Q2 | $-0.84 | $-0.89 | -6.5% |
| 2025Q1 | $0.81 | $0.92 | +13.9% |
| 2024Q4 | $-0.58 | $-0.62 | -6.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*